090370.KO MetaLabs Co Ltd
- Market cap
- KRW 26.3B
- P/E
- -
- P/B
- 0.31x
- ROE
- -7.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 090370.KO undervalued?
Graham numberThe Graham number of MetaLabs Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
MetaLabs Co Ltd fundamental analysis
No fundamental analysis for MetaLabs Co Ltd yet.
MetaLabs Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About MetaLabs Co Ltd
Metalabs Co., Ltd. primarily provides clothing, miscellaneous goods, and accessories in South Korea. The company sell goods, such as cosmetics; operates hospital management support, block chain and virtual currency development services, etc.; and social dating services. The company was formerly known as Avista Inc. and changed its name to Metalabs Co., Ltd. in April 2018. Metalabs Co., Ltd. was founded in 2000 and is based in Seoul, South Korea.
Full company profileMetaLabs Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
MetaLabs Co Ltd annual financial statements (KRW; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 92.1B | 26.8B | 47.4B | 86.9B | 83.4B | 39.3B | 22.7B | 21.6B | 38.4B | 81.3B | 116B |
| Gross Profit | 33.6B | 8.32B | 19.0B | 29.1B | 28.0B | 20.3B | 9.61B | 6.29B | 8.90B | 9.89B | 19.1B |
| Operating Income | -32.5B | -15.9B | -8.80B | -1.96B | -1.12B | -1.39B | -2.01B | -3.86B | -3.20B | -7.24B | 1.56B |
| EBITDA | - | -30.8B | -9.40B | -15.5B | -13.7B | -12.3B | -8.47B | -4.78B | 3.21B | -3.81B | 4.16B |
| Net Income | -39.2B | -37.9B | -13.5B | -24.9B | -18.6B | -14.5B | -4.10B | -7.30B | 197M | -8.79B | -6.38B |
| EPS | - | -1,255 | -304 | -476 | -293 | -196 | -822 | -293 | 7.91 | -353 | -256 |
| Balance Sheet | |||||||||||
| Total Assets | 76.7B | 49.4B | 107B | 98.3B | 77.0B | 85.0B | 90.0B | 112B | 133B | 250B | 294B |
| Total Liabilities | 53.3B | 19.1B | 33.9B | 39.7B | 23.6B | 28.6B | 11.1B | 38.5B | 53.8B | 108B | 138B |
| Shareholders' Equity | 23.4B | 30.3B | 67.5B | 56.9B | 53.0B | 52.0B | 78.7B | 71.8B | 78.1B | 69.9B | 86.3B |
| Cash & Short-term Investments | 15.4B | 9.53B | 16.5B | 6.15B | 3.34B | 11.2B | 2.04B | 1.67B | 1.70B | 4.06B | 12.3B |
| Cash Flow | |||||||||||
| Operating Cash Flow | -10.0B | -8.47B | -6.90B | -4.02B | 1.36B | 2.28B | 448M | -49.6M | -3.83B | -2.50B | 6.28B |
| Capital Expenditure | 1.91B | 1.09B | 1.10B | 1.31B | 2.22B | 145M | 325M | 492M | 778M | 1.52B | 235M |
| Free Cash Flow | - | -9.55B | -9.13B | -7.77B | -1.00B | 1.87B | -2.12B | -541M | -4.61B | -4.02B | 6.04B |
| Ratios | |||||||||||
| ROE | -167.8% | -125.0% | -20.0% | -43.8% | -35.2% | -27.9% | -5.2% | -10.2% | 0.3% | -12.6% | -7.4% |
| ROA | -51.1% | -76.7% | -12.6% | -25.4% | -24.2% | -17.1% | -4.6% | -6.5% | 0.1% | -3.5% | -2.2% |
| Net Profit Margin | -42.6% | -141.4% | -28.5% | -28.7% | -22.3% | -36.9% | -18.1% | -33.8% | 0.5% | -10.8% | -5.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
MetaLabs Co Ltd dividends
MetaLabs Co Ltd has not paid dividends in the last 9 fiscal years.
Last stock split: 1:5 on Dec 2, 2022.
Who owns MetaLabs Co Ltd
- Insiders 59.74%
- Institutions 0.03%
- Public & others 40.23%
- Shares outstanding 27.3M
- Free float 11.0M
MetaLabs Co Ltd company profile
- Company name
- MetaLabs Co Ltd
- Ticker
- 090370.KO
- ISIN
- KR7090370008
- Exchange
- Korea Stock Exchange
- Listed since
- Dec 26, 2006
- Sector
- Consumer Cyclical
- Industry
- Textiles, Apparel & Luxury Goods
- Employees
- 19
- Fiscal year end
- December
- Address
- 428 Eonju-ro, Seoul, South Korea
- Phone
- 82 2 2189 7700
- Website
- metalabs.co.kr
About MetaLabs Co Ltd
Metalabs Co., Ltd. primarily provides clothing, miscellaneous goods, and accessories in South Korea. The company sell goods, such as cosmetics; operates hospital management support, block chain and virtual currency development services, etc.; and social dating services. The company was formerly known as Avista Inc. and changed its name to Metalabs Co., Ltd. in April 2018. Metalabs Co., Ltd. was founded in 2000 and is based in Seoul, South Korea.
MetaLabs Co Ltd management
4- Mr. Dong Keun KimChief Executive Officer · born 1968
- Mr. Bang Seob ShinChief Financial Officer and Managing Director · born 1970
- Mr. Jae Han ParkDirector of Sales and Director · born 1965
- Jin Soo ChungSales Director of Second Sales Division and Director · born 1965